WIRED Examines Underrepresentation Of Women In HIV Prevention Drug Trials Testing PrEP
WIRED: The Dangers of Excluding Women From HIV Prevention Drug Tests
“…The underrepresentation of women in all kinds of medical research — from heart disease to sexual dysfunction — is a longstanding concern among women’s health activists. With HIV, inequity not only leaves women vulnerable to a life-altering disease, but it also thwarts efforts to stop its spread. … Gender disparity in HIV treatment and research dates back to the earliest days of the epidemic, when it was viewed almost exclusively as a disease of young, white, gay men. … Diseases associated with AIDS in women were different — which meant they had more difficulty getting diagnosed and accessing housing aid, disability payments, and other social services. … [S]o far, PrEP studies have a mixed track record for including women…” (Marill, 6/10).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.